Truist bullish on Eli Lilly stock, sees growth from obesity and cardiometabolic...

Published on 9 Jan 2025 on Investing.com

On Wednesday, Truist Securities reaffirmed their Buy rating on Eli Lilly (NYSE:LLY) shares with a...

Read the rest of the article

Start tracking your investments with Statfolio

In the latest market close, Organon (OGN) reached $15.97, with a +0.82% movement compared to the ...

Zacks · via Yahoo Finance 30 Jan 2025

Key Insights Given the large stake in the stock by institutions, Organon's stock price might be...

Simply Wall St. · via Yahoo Finance 28 Jan 2025

Organon (OGN) closed the most recent trading day at $16.26, moving +1.82% from the previous tradi...

Zacks · via Yahoo Finance 27 Jan 2025

The latest trading session saw Organon (OGN) ending at $15.85, denoting a -0.94% adjustment from ...

Zacks · via Yahoo Finance 11 Jan 2025

Exposure to radon was linked to an increased risk for gestational diabetes, a population-based...

MedPage Today 10 Jan 2025

Bacterial vaginosis (BV) is a super common infection that happens when you get an overgrowth of...

Well and Good 9 Jan 2025

On Wednesday, Truist Securities reaffirmed their Buy rating on Eli Lilly (NYSE:LLY) shares with a...

Investing.com 9 Jan 2025

Organon (OGN) closed at $16 in the latest trading session, marking a +1.78% move from the prior d...

Zacks · via Yahoo Finance 9 Jan 2025

Metformin and glyburide fell short of achieving noninferiority with insulin

MedPage Today 6 Jan 2025

Organon (OGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a g...

Zacks · via Yahoo Finance 30 Dec 2024